Patent intelligence · US
US 10538530
Vasopressin receptor antagonists and products and methods related thereto
Vasopressin receptor antagonists and products and methods related thereto
Patent details — US 10538530
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 21, 2020
- Expiration
- Jan 16, 2040
- Applicant
- BLACKTHORN THERAPEUTICS, INC.
- Claims
- 104
- CPC classes
- A61P, A61P25/00, A61P25/18, A61P25/20
Quick answer
US 10538530 (Vasopressin receptor antagonists and products and methods related thereto) is held by BLACKTHORN THERAPEUTICS, INC.. Status: granted. Granted Jan 21, 2020. Expires Jan 16, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BLACKTHORN THERAPEUTICS, INC.
- Grant date
- Expiration
- Claims
- 104
- CPC classes
- A61P, A61P25/00, A61P25/18, A61P25/20, A61P25/22, A61P25/24
More from BLACKTHORN THERAPEUTICS, INC.
Related pharmaceutical patents in our USPTO index.
-
US 12343394
CD38 modulating antibody agents
granted -
US 12325699
Antibacterial compounds
granted -
US 12304964
CD38 modulating antibody
granted -
US 12187754
LpxC inhibitors and uses thereof
granted -
US 12161717
CD38 modulating antibody agents
granted -
US 12162949
CD38 antibody
granted -
US 11897873
Kappa opioid receptor antagonists and products and methods related thereto
granted -
US 11780930
CD38 modulating antibody
granted
Frequently asked questions
What is US patent 10538530?
US 10538530 (Vasopressin receptor antagonists and products and methods related thereto) is held by BLACKTHORN THERAPEUTICS, INC.. Status: granted. Granted Jan 21, 2020. Expires Jan 16, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10538530?
BLACKTHORN THERAPEUTICS, INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 38 pharmaceutical patents for this assignee.
When does US 10538530 expire?
Our index shows an expiration date of Jan 16, 2040 (14 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.